Dr. Worster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
# 420A
Philadelphia, PA 19107Phone+1 215-955-1888Fax+1 215-503-3152
Summary
- Brooke Worster, MD, is an internal medicine specialist based in Philadelphia, PA, with a focus on Hospice & Palliative Medicine and Pain Medicine. She completed her education and residency at the Lewis Katz School of Medicine at Temple University and Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women's Hospital respectively. Currently, Dr. Worster serves as the Division Director of Supportive Oncology at Jefferson Health and the Medical Director of Palliative Care Service at Thomas Jefferson University Hospitals. She has significant contributions to medical literature, with numerous publications in esteemed journals, and she has taken part in various clinical trials mainly focused on the use of cannabis in cancer treatment and telehealth care.
Education & Training
- Massachusetts General Hospital/Dana-Farber Cancer Institute/Children's Hospital BostonFellowship, Hospice and Palliative Medicine, 2012
- Temple University HospitalResidency, Internal Medicine, 2007 - 2010
- Lewis Katz School of Medicine at Temple UniversityClass of 2007
- Temple University HospitalChief Residency, Internal Medicine
Certifications & Licensure
- DE State Medical License 2022 - 2025
- NJ State Medical License 2018 - 2025
- PA State Medical License 2007 - 2024
- MA State Medical License 2011 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
Clinical Trials
- Cannabis Use Patterns Among Cancer Patients Start of enrollment: 2021 Feb 25
Roles: Contact
- Telehealth-enabled Integrated Palliative Care for People With Dementia Start of enrollment: 2022 Jun 29
Roles: Principal Investigator, Contact
- IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer Start of enrollment: 2024 May 30
Roles: Contact
Publications & Presentations
PubMed
- 7 citationsMonthly "Grief Rounds" to Improve Residents' Experience and Decrease Burnout in a Medical Intensive Care Unit Rotation.Lindsay Wilde, Brooke Worster, David Oxman
American Journal of Medical Quality. 2016-05-23 - 6 citationsImpact of Cannabis Use on Least Pain Scores Among African American and White Patients with Cancer Pain: A Moderation Analysis.Salimah H. Meghani, Ryan Quinn, Rebecca L. Ashare, Kristin Levoy, Brooke Worster
Journal of Pain Research. 2021-11-05 - 226 citationsOnline Medical Professionalism: Patient and Public Relationships: Policy Statement From the American College of Physicians and the Federation of State Medical BoardsJeanne M. Farnan, Lois Snyder Sulmasy, Brooke Worster, Humayun J. Chaudhry, Janelle A. Rhyne
Annals of Internal Medicine. 2013-04-16
Press Mentions
- Cannabis in Cancer: What Oncologists and Patients Should KnowOctober 22nd, 2024
- Independence Blue Cross and Jefferson Health Study Published in the Journal Cancer Finds Outpatient Supportive Oncology Programs Improve Care and Reduce CostsAugust 6th, 2024
- Independence Blue Cross Awards 2022 Clinical Care Innovation Grants to Jefferson Health, Temple Health, Penn Medicine, and Trinity Health Mid-AtlanticJuly 8th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: